Trividia TRUE METRIX.
By Trividia Health Solutions
No-coding-required cellular glucose meter with automatic data transmission, designed for RPM programs managing diabetes across senior care and primary care settings.

Specifications
Key specs.
Connectivity
Cellular (built-in SIM)
Test Time
4 seconds
Sample Size
0.5 microliters
Measurement Range
20-600 mg/dL
Coding
No coding required
Memory
1,000 test results with date and time
Features
Key features.
No coding required for test strips
Cellular connectivity with automatic data upload
Small sample size reduces patient discomfort
4-second test results for quick readings
Large memory capacity for 1,000 results
Quad-electrode strip technology for accuracy
Use Cases
Clinical applications.
Type 2 diabetes daily glucose management
Type 1 diabetes monitoring in senior care
Gestational diabetes surveillance
Pre-diabetes intervention programs
Metabolic syndrome monitoring
Precision Glucose Monitoring for RPM Programs
Diabetes affects over 37 million Americans, with the highest prevalence concentrated in adults over age 65. Effective glucose management depends on regular, accurate blood glucose monitoring that captures the day-to-day patterns clinicians need to guide medication titration, dietary counseling, and care plan adjustments. The Trividia TRUE METRIX cellular glucose meter brings clinical-grade accuracy to the home monitoring environment, with automatic data transmission that eliminates the delays and data gaps that undermine traditional self-monitoring programs.
Integrated with CCNHealth, each glucose reading is transmitted within seconds to the clinical dashboard, where care teams can evaluate trends, flag concerning values, and intervene before glycemic events escalate into emergency situations.
How the TRUE METRIX Works with CCNHealth
Cellular-Connected Glucose Testing
The TRUE METRIX meter includes a built-in cellular module that transmits glucose results to CCNHealth automatically after each test. This cellular-first design eliminates the connectivity challenges that plague Bluetooth-dependent glucometers:
- No smartphone required — Results transmit directly over the cellular network
- No pairing procedures — The device is pre-configured before shipping
- No app dependencies — There is no software for the patient to install, update, or troubleshoot
- No WiFi needed — Works anywhere with cellular coverage
For patients in rural areas, assisted living facilities, or households without reliable internet, this architecture ensures consistent data flow regardless of the local technology environment.
No-Code Strip Technology
The TRUE METRIX uses Trividia's proprietary quad-electrode strip technology, which requires no coding. Patients simply insert a test strip, apply a small blood sample of just 0.5 microliters, and receive their result in four seconds. The no-coding design eliminates a common source of user error in glucose testing, where incorrect coding can produce inaccurate results.
The small sample size is particularly valuable for elderly patients and those who test frequently. A smaller lancet depth produces a smaller blood drop, which may help reduce discomfort and improve long-term testing adherence.
Glucose Data Analysis on CCNHealth
Each reading arrives at the CCNHealth platform with a timestamp and is processed through the clinical rules engine:
- Hypoglycemia alert — Readings below 70 mg/dL trigger an immediate notification, with critical alerts for values below 54 mg/dL
- Hyperglycemia flag — Fasting readings above 130 mg/dL or post-meal readings above 180 mg/dL generate clinical alerts
- Trend analysis — Seven-day and 30-day glucose averages are calculated automatically to estimate glycemic control
- Estimated A1c — The platform calculates an estimated HbA1c from average glucose data, providing a running indicator between laboratory draws
- Pattern recognition — Recurring episodes of hypoglycemia or hyperglycemia at specific times of day are identified and flagged for medication review
- Missed readings — Non-compliance alerts are generated when expected test times are missed
All thresholds are configurable per patient to accommodate individualized glycemic targets.
Clinical Applications
Type 2 Diabetes Management
Type 2 diabetes is the most common qualifying condition for glucose-based RPM enrollment. Studies suggest that structured self-monitoring of blood glucose, when combined with clinical oversight and feedback, may help improve glycemic control in patients with Type 2 diabetes. The TRUE METRIX enables daily or multi-daily testing with automatic data capture, providing the longitudinal glucose data that supports medication adjustments, dietary interventions, and patient education.
For patients on oral hypoglycemic agents, daily fasting glucose monitoring helps clinicians assess medication effectiveness. For those on insulin therapy, pre-meal and post-meal testing guides insulin dose titration and identifies problematic glycemic patterns.
Type 1 Diabetes in Senior Care
Older adults with Type 1 diabetes face unique monitoring challenges, including hypoglycemia unawareness, cognitive decline affecting self-management skills, and increased fall risk from glycemic variability. The cellular-connected TRUE METRIX ensures that glucose data reaches the care team even when patients may have difficulty remembering to manually log or report their results.
Gestational Diabetes Monitoring
For pregnant patients with gestational diabetes, tight glycemic control is essential for maternal and fetal outcomes. The TRUE METRIX supports the multi-daily testing schedule typically recommended during pregnancy, with automatic transmission ensuring that obstetric teams have real-time visibility into glucose patterns. Research indicates that close glucose monitoring during gestational diabetes may help reduce complications including macrosomia and neonatal hypoglycemia.
Pre-Diabetes Intervention
For patients with pre-diabetes, glucose monitoring serves as both a clinical tool and a behavioral motivator. Seeing the impact of dietary choices and physical activity on blood glucose in near-real-time can reinforce lifestyle modifications. The TRUE METRIX provides objective data that supports patient education and engagement in prevention programs.
Integration and Billing
RPM Revenue with Glucose Monitoring
Glucose monitoring with the TRUE METRIX supports the full RPM CPT code set. Each testing day counts toward the 16-day minimum transmission requirement:
| CPT Code | Service | Typical Reimbursement |
|---|---|---|
| 99453 | Initial setup and patient education | ~$19 (one-time) |
| 99454 | Device supply with daily recordings | ~$55/month |
| 99457 | First 20 minutes clinical review | ~$48/month |
| 99458 | Each additional 20 minutes review | ~$38/month |
Multi-Service Eligibility
Most patients with diabetes have additional chronic conditions, making them strong candidates for CCM or PCM billing alongside RPM. A patient with uncontrolled Type 2 diabetes plus hypertension, for example, may qualify for RPM (glucose monitoring), CCM (multi-condition care coordination), and potentially PCM (complex single-condition management), significantly increasing per-patient monthly revenue.
EHR Documentation
Glucose readings from CCNHealth integrate into connected EHR systems with full metadata. Each result includes the timestamp, device identifier, and any associated alert flags, supporting clinical documentation requirements and enabling longitudinal glucose trend review within the patient chart.
Test Strip Supply Management
Consistent Supply Chain
Maintaining an uninterrupted supply of test strips is critical for RPM program compliance. CCNHealth supports test strip management through:
- Automated reorder tracking — Estimated strip consumption based on prescribed testing frequency
- Direct-to-patient fulfillment — Strips shipped to the patient's address on a scheduled cadence
- Inventory visibility — Dashboard indicators for patients approaching supply depletion
- Insurance coordination — Support for Medicare and commercial payer coverage of test strips
Strip Accuracy and Quality
TRUE METRIX test strips use quad-electrode biosensor technology that measures glucose levels while simultaneously running quality control checks on each test. The system detects insufficient sample volume, partially filled strips, and environmental factors that could affect accuracy, rejecting invalid tests rather than reporting potentially inaccurate results.
Getting Started
Deploying the Trividia TRUE METRIX in your CCNHealth RPM program is a streamlined process:
- Patient identification — Identify patients with diabetes, pre-diabetes, or metabolic conditions requiring regular glucose monitoring
- Device provisioning — CCNHealth ships pre-configured meters with an initial supply of test strips and lancets
- Patient training — Brief orientation on the testing process: insert strip, apply sample, wait four seconds
- Monitoring activation — First glucose reading triggers automatic account activation and dashboard enrollment
- Ongoing management — Care teams review glucose trends, respond to alerts, and coordinate test strip resupply
Contact CCNHealth to integrate the Trividia TRUE METRIX into your diabetes remote monitoring program.
Device specifications are sourced from manufacturer published data and are subject to change. Always verify current specifications with the manufacturer before clinical deployment.
Questions?
Want to learn more about the Trividia TRUE METRIX for your program?
Our team can answer your questions and show you how it works with your current workflow.

